Merix Pharmaceutical Corp. unveiled its new Fast-Results!™ Genital Herpes Treatment March 1st while attending a retail industry trade show in Dallas. The first ever OTC treatment for genital herpes, Fast-Results! answers the unmet need of people who suffer painful symptoms caused by the herpes virus. Intended to be used in conjunction with prescription medication, Fast-Results! brings effective and affordable treatment to consumers who cannot afford the high cost of prescriptions.
Already a leader in the cold sore treatment market with its patented Viracea® formula found in RELEEV 1 Day Cold Sore Symptom Treatment, Merix is now bringing its technology to deliver fast symptom relief to the genital herpes sufferer.
Fast-Results! Genital Herpes Treatment is comprised of Merix' patented technology Viracea® which is approved under the FDA OTC Antiseptic/Antimicrobial Monograph. Fast-Results! also includes Merix' new patented technology that is also approved under FDA OTC Monographs. Provided in a topical spray, Fast-Results!™ quickly and effectively relieves the pain, burning, and itching caused by genital herpes. At clinical trial, Viracea® was shown to be very effective and very fast at healing herpes caused lesions.
The Center for Disease Control recently reported that 1 in 6 people in the U.S. between the ages of 14 and 49 suffer from genital herpes. That is greater than 37 million people and if older ages are included, the number is even larger.